• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例继发于肿瘤性骨软化症的甲状旁腺功能亢进症。

A case of hyperparathyroidism secondary to tumor-induced osteomalacia.

机构信息

Department of Endocrinology, Third Xiangya Hospital, Central South University, Changsha 410013.

Department of Clinical Laboratory, Third Xiangya Hospital, Central South University, Changsha 410013, China.

出版信息

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Dec 28;48(12):1937-1944. doi: 10.11817/j.issn.1672-7347.2023.220547.

DOI:10.11817/j.issn.1672-7347.2023.220547
PMID:38448388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10930739/
Abstract

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome in which tumor-induced osteochondrosis is a metabolic bone disease caused by increased renal excretion of phosphorus due to excessive secretion of fibroblast growth factor 23 (FGF23) by tumor tissue. We report here a rare case of TIO in which the tumor was found in the hyoid body and the patient had tertiary hyperparathyroidism. The patient's symptoms did not improve after removal of the tumor from the hyoid body, and the patient's hypophosphatemia was gradually improved after subsequent removal of the left parathyroid gland. TIO derived from the tongue tumor is very rare, and also subsequent tertiary hyperparathyroidism is even rarer. This report helps to improve the understanding of TIO and provides reference in the diagnosis and treatment of TIO.

摘要

肿瘤相关性骨软化症(TIO)是一种罕见的副瘤综合征,其中肿瘤诱导性骨软骨病是一种代谢性骨病,由肿瘤组织过度分泌成纤维细胞生长因子 23(FGF23)导致肾脏磷排泄增加引起。我们在此报告一例罕见的 TIO 病例,肿瘤位于舌骨,患者患有三级甲状旁腺功能亢进症。患者的症状在切除舌骨肿瘤后并未改善,随后切除左甲状旁腺后,患者的低磷血症逐渐改善。来源于舌肿瘤的 TIO 非常罕见,并且继发的三级甲状旁腺功能亢进症更为罕见。本报告有助于提高对 TIO 的认识,并为 TIO 的诊断和治疗提供参考。

相似文献

1
A case of hyperparathyroidism secondary to tumor-induced osteomalacia.一例继发于肿瘤性骨软化症的甲状旁腺功能亢进症。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Dec 28;48(12):1937-1944. doi: 10.11817/j.issn.1672-7347.2023.220547.
2
Hyperparathyroidism in a Large Cohort of Chinese Patients With Tumor-induced Osteomalacia.一大群中国肿瘤诱导性骨软化症患者的甲状旁腺功能亢进症
J Clin Endocrinol Metab. 2023 Apr 13;108(5):1224-1235. doi: 10.1210/clinem/dgac650.
3
Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.肿瘤诱导的骨软化症——一种超越疼痛、抑郁的神秘疾病。
Endocr Regul. 2021 Sep 13;55(3):163-168. doi: 10.2478/enr-2021-0017.
4
A rare combination of tumor-induced osteomalacia caused by sinonasal glomangiopericytoma and coexisting parathyroid adenoma: case report and literature review.鼻腔鼻窦血管外皮细胞瘤伴发甲状旁腺腺瘤导致的肿瘤性骨软化症罕见病例报告并文献复习。
BMC Endocr Disord. 2022 Jan 28;22(1):31. doi: 10.1186/s12902-022-00934-7.
5
A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.一例罕见的沿腱鞘多发磷尿性间叶肿瘤致骨软化症病例。
BMC Musculoskelet Disord. 2017 Feb 13;18(1):79. doi: 10.1186/s12891-017-1446-z.
6
Long-term use of burosumab for the treatment of tumor-induced osteomalacia.布罗索尤单抗治疗肿瘤相关性骨软化症的长期应用。
Osteoporos Int. 2023 Jan;34(1):201-206. doi: 10.1007/s00198-022-06516-6. Epub 2022 Aug 4.
7
Tumor-induced osteomalacia.肿瘤诱导的骨软化症。
Bone Rep. 2017 Sep 20;7:90-97. doi: 10.1016/j.bonr.2017.09.002. eCollection 2017 Dec.
8
Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23.通过磁共振成像和FGF23静脉采样联合程序诊断的肿瘤诱导的低磷性骨软化症
Intern Med. 2008;47(10):957-61. doi: 10.2169/internalmedicine.47.0745. Epub 2008 May 15.
9
Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.与产生成纤维细胞生长因子23的颌面部肿瘤相关的肿瘤诱导性骨软化症:一例报告并文献复习
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Mar;109(3):e57-63. doi: 10.1016/j.tripleo.2009.10.052.
10
Tumour-induced osteomalacia: a literature review and a case report.肿瘤诱导的骨软化症:文献综述与病例报告
World J Surg Oncol. 2016 Jan 8;14(1):4. doi: 10.1186/s12957-015-0763-7.

引用本文的文献

1
Failure of femoral internal fixation device secondary to phosphaturic mesenchymal tumor: a case report and literature review.继发于磷尿性间叶肿瘤的股骨内固定装置失效:1例病例报告及文献复习
BMC Musculoskelet Disord. 2025 Sep 1;26(1):831. doi: 10.1186/s12891-025-09066-0.
2
Clinical features and treatment of hypophosphatemia and associated complications induced by Phosphaturic mesenchymal tumors: A case series of six patients.磷尿性间叶肿瘤所致低磷血症及其相关并发症的临床特征与治疗:6例病例系列报告
Bone Rep. 2024 Dec 31;24:101822. doi: 10.1016/j.bonr.2024.101822. eCollection 2025 Mar.

本文引用的文献

1
High bone turnover and hyperparathyroidism after surgery for tumor-induced osteomalacia: A case series.肿瘤诱导性骨软化症手术后的高骨转换和甲状旁腺功能亢进:病例系列
Bone Rep. 2021 Oct 9;15:101142. doi: 10.1016/j.bonr.2021.101142. eCollection 2021 Dec.
2
Epidemiology of Tumor-Induced Osteomalacia in Denmark.丹麦肿瘤相关性骨软化症的流行病学研究。
Calcif Tissue Int. 2021 Aug;109(2):147-156. doi: 10.1007/s00223-021-00843-2. Epub 2021 Apr 5.
3
Tumor-Induced Osteomalacia.肿瘤相关性骨软化症。
Calcif Tissue Int. 2021 Jan;108(1):128-142. doi: 10.1007/s00223-020-00691-6. Epub 2020 Jun 5.
4
Phosphaturic mesenchymal tumors: A review and update.磷酸尿嘧啶酶肿瘤:综述与更新。
Semin Diagn Pathol. 2019 Jul;36(4):260-268. doi: 10.1053/j.semdp.2019.07.002. Epub 2019 Jul 5.
5
Tumor-induced osteomalacia.肿瘤诱导的骨软化症
Osteoporos Sarcopenia. 2018 Dec;4(4):119-127. doi: 10.1016/j.afos.2018.12.001. Epub 2018 Dec 12.
6
Tumor-induced osteomalacia.肿瘤诱导的骨软化症。
Bone Rep. 2017 Sep 20;7:90-97. doi: 10.1016/j.bonr.2017.09.002. eCollection 2017 Dec.
7
Tumour-induced osteomalacia.肿瘤相关性骨软化症。
Nat Rev Dis Primers. 2017 Jul 13;3:17044. doi: 10.1038/nrdp.2017.44.
8
The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases.肿瘤诱导性骨软化症的诊断困境:144例回顾性分析
Endocr J. 2017 Jul 28;64(7):675-683. doi: 10.1507/endocrj.EJ16-0587. Epub 2017 May 26.
9
Tumour-induced osteomalacia: a literature review and a case report.肿瘤诱导的骨软化症:文献综述与病例报告
World J Surg Oncol. 2016 Jan 8;14(1):4. doi: 10.1186/s12957-015-0763-7.
10
From epistaxis to bone pain-report of two cases illustrating the clinicopathological spectrum of phosphaturic mesenchymal tumour with fibroblast growth factor receptor 1 immunohistochemical and cytogenetic analyses.从鼻出血到骨痛——两例纤维母细胞生长因子受体 1 免疫组织化学和细胞遗传学分析的磷酸尿苷肿瘤临床病理谱的病例报告。
Histopathology. 2016 May;68(6):925-30. doi: 10.1111/his.12872. Epub 2015 Nov 25.